Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis

Completed · Not applicable

Conditions studied: Meibomian Gland Dysfunction, Dry Eye, Posterior Blepharitis

In brief

The goal of this study is to compare which treatment - BlephEx or MiBoFlo - will be a better option for patients suffering from dry eye secondary to Meibomian Gland dysfunction.

Key facts

Study ID

NCT02952079

Run by

University of the Incarnate Word

People needed

11

Starts

2015-05-01

Expected to finish

2018-04-01

Last updated by the study team

2018-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must have dry eye secondary to Meibomian gland dysfunction (posterior blepharitis)

You may not qualify if…

• Must not have active ocular surface infections. Must not be currently using steroids or immunosuppression eye drops.

Where it is running

• Rosenberg School of Optometry — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.